Oridonin New
Chemical Name: 7α,20-Epoxy-1α,6β,7,14-tetrahydroxykaur-16-en-15-one
Purity: ≥98%
Biological Activity
High affinity NLRP3 inflammasome inhibitor (Kd = 52.5 nM). Forms covalent bind within NACHT domain and blocks interaction of NLRP3 with NEK7 to inhibit assembly and activation of inflammasome. Inhibits glial activation, decreases inflammatory cytokine release, attenuates synaptic loss and improves behavioural deficits in Aβ1-42 treated mice. Also displays anti-cancer properties in various cancer cell lines.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Oridonin attenuates Aβ1-42-induced neuroinflammation and inhibits NF-κB pathway.
Wang et al.
PLoS One, 2014;9:e104745 -
Oridonin attenuates synaptic loss and cognitive deficits in an Aβ1-42-induced mouse model of alzheimer's disease.
Wang et al.
PLoS One, 2016;11:e0151397 -
Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity.
He et al.
Nat.Commun., 2018;9:2550 -
Oridonin induces G2/M cell cycle arrest and apoptosis in human oral squamous cell carcinoma.
Wang et al.
Eur.J.Pharmacol., 2017;815:282 -
Oridonin induces autophagy via inhibition of glucose metabolism in p53-mutated colorectal cancer cells.
Yao et al.
Cell Death Dis., 2017;8:e2633
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Oridonin
There are currently no reviews for this product. Be the first to review Oridonin and earn rewards!
Have you used Oridonin?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
